alarm
situat
caus
due
emerg
infect
around
world
urgenc
develop
therapeut
strategi
order
control
spread
toward
initi
potenti
drug
like
hydroxychloroquin
ivermectin
azithromycin
test
divers
group
research
worldwid
potenti
novel
coronaviru
present
report
present
togeth
comprehens
knowledg
deriv
major
research
drug
altogeth
context
current
health
emerg
around
world
hydroxychloroquin
ivermectin
known
act
creat
acid
environ
inhibit
importin
mediat
viral
import
azithromycin
found
act
similar
hydroxychloroquin
acidotrop
lipophil
weak
base
three
categori
drug
seem
potenti
act
novel
coronaviru
infect
howev
efficaci
need
studi
detail
individu
combin
invivo
order
combat
infect
azithromycin
shown
therapeut
effect
novel
coronaviru
infect
howev
report
drug
better
efficaci
comparison
combin
give
life
save
result
therefor
present
report
abl
provid
comprehens
view
combin
knowledg
drug
altogeth
context
current
health
emerg
around
world
first
categori
drug
chloroquin
safer
deriv
hydroxychloroquin
may
act
therapeut
agent
infect
earlier
use
wide
treatment
rheumatoid
arthriti
system
lupu
erythematosu
chloroquin
initi
use
treatment
malaria
plasmodium
falciparum
substanti
develop
resist
subsequ
develop
new
antimalari
drug
use
prophylaxi
malaria
introduct
hydroxyl
group
chloroquin
deriv
produc
known
hydroxychloroquin
found
less
acut
poison
former
one
drug
otherwis
share
similar
mechan
action
structur
drug
tend
increas
ph
within
intracellular
vacuol
act
weak
base
addit
known
alter
process
protein
degrad
acid
hydrolas
lysosom
assembl
macromolecul
endosom
post
translat
modif
protein
golgi
apparatu
past
decad
drug
receiv
wider
attent
potenti
antivir
drug
chang
colleagu
reveal
hydroxychloroquin
activ
host
antivir
innat
immun
drug
accumul
cellular
organel
creat
acid
environ
anoth
studi
reveal
ivermectin
broad
spectrum
antiparasit
drug
demonstr
efficaci
come
second
line
drug
ivermectin
fda
approv
drug
known
widespectrum
antivir
activ
number
virus
vitro
condit
caus
agent
singl
strand
rna
viru
posit
sens
close
relat
sar
condit
reveal
inhibit
viral
replic
singl
treatment
drug
abl
reduc
viru
cultur
within
howev
reduct
report
increas
time
period
ie
moreov
toxic
seen
drug
point
time
mechan
ivermectin
respond
viru
known
believ
work
similarli
act
virus
known
inhibit
nuclear
import
viral
host
protein
integras
protein
virus
importin
imp
heterodim
respons
nuclear
import
increas
infect
figur
rna
virus
depend
upon
infect
ivermectin
act
inhibit
import
increas
antivir
respons
third
categori
therapeut
drug
azithromycin
class
antibiot
known
macrolid
use
treat
infect
like
bronchiti
pneumonia
mac
mycobacterium
avium
complex
infect
spread
viral
pneumonia
start
wuhan
china
mani
countri
world
start
develop
countermeasur
order
decreas
spread
diseas
research
found
apart
hydroxychloroquin
anoth
fda
approv
drug
known
azithromycin
shown
therapeut
effect
studi
done
research
group
new
mexico
univers
research
abl
prove
azithromycin
act
acidotrop
lipophil
weak
base
modul
ph
endosom
transgolgi
network
figur
led
vitro
effect
intracellular
organel
similar
one
confer
hydroxychloroquin
indic
antimicrobi
drug
immens
therapeut
valu
far
treatment
patient
concern
clinic
trial
need
carri
drug
act
prophylaxi
declin
infect
rate
drug
shown
potenti
broadspectrum
antivir
respons
vitro
mani
virus
includ
coronavirus
howev
hydroxychloroquin
found
associ
danger
sideeffect
past
dosag
care
control
mani
case
chloroquin
poison
report
nigeria
usa
well
due
sudden
rapid
increas
demand
broadspectrum
drug
may
lead
signific
shortag
patient
reli
drug
treat
disord
like
malaria
rheumatoid
arthriti
among
other
therefor
adequ
buffer
stock
maintain
drug
overcom
potenti
scarciti
abovement
drug
three
categori
drug
seem
act
novel
coronaviru
infect
howev
research
use
larg
cohort
sampl
random
control
clinic
trial
urgent
requir
drug
alon
incombin
order
find
concret
solut
infect
